Skip to main content

Cutaneous Melanoma and Oral Contraceptives: A Review of Case-Control and Cohort Studies

  • Conference paper

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 102))

Abstract

There is biological evidence for the hypothesis that the frequency of malignant melanoma is influenced by hormonal or reproductive factors. Estrogen receptors have been found in human malignant melanoma cells, though the percent age that are estrogen positive varies considerably by study (Creagan et al. 1980; Fisher et al. 1976). Estrogens and progesterone together or estrogen alone increase the number of melanocytes and the intracellular and extracellular melanin content in guinea pigs (Snell and Bischitz 1960). Ultraviolet light exposure causes darkening of the skin pigment and is believed to play a role in the etiology of melanoma (Holman and Armstrong 1984). Estrogens, whether administered topically (Jadassohn 1958), used to relieve menopausal symptoms (Hamilton 1939), or taken for contraception, can also produce hyperpigmentation, the degree of darkening increasing with duration of use (Carruthers 1966).

The work reported in this paper was supported in part by NCl grants CA 34382 and CA 19408

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Abbreviations

MM :

malignant melanoma

SSM :

superficial spreading melanoma

NM :

nodular melanoma

OC :

oral contraceptives

References

  • Adam SA, Sheaves JK, Wright NH, Mosser RW, Vessey MP (1981) A case-control study of the possible association between oral contraceptives and malignant melanoma. Br J Cancer 44: 45–50

    Article  PubMed  CAS  Google Scholar 

  • Bain C, Hennekens CH, Speizer FE, Rosner B, Willett W, Belanger C (1982) Oral contraceptive use and malignant melanoma. JNC I 68: 537–539

    CAS  Google Scholar 

  • Beral V, Ramcharan S, Faris R (1977) Malignant melanoma and oral contraceptive use among women in California. Br J Cancer 36: 804–809

    Article  PubMed  CAS  Google Scholar 

  • Beral V, Evans S, Shaw H, Milton G (1984) Oral contraceptive use and malignant melanoma in Australia. Br J Cancer 50: 681–685

    Article  PubMed  CAS  Google Scholar 

  • Carruthers R (1966) Chloasma and oral contraceptives. Med J Aust 2: 17–20

    PubMed  CAS  Google Scholar 

  • Creagan ET, Ingle JN, Woods JE, Pritchard DJ, Jiang NS (1980) Estrogen receptors in patients with malignant melanoma. Cancer 46: 1785–1786

    Article  PubMed  CAS  Google Scholar 

  • Fisher RI, Neifeld JP, Lippman ME (1976) Oestrogen receptors in human malignant melanoma. Lancet 2: 337–338

    Article  PubMed  CAS  Google Scholar 

  • Gallagher RP, Elwood JM, Hill GB, Coldman AJ, Threlfall WJ, Spinelli JJ (1985) Reproductive factors, oral contraceptives and risk of malignant melanoma: Western Canada melanoma study. Br J Cancer 52: 901–907

    Article  PubMed  CAS  Google Scholar 

  • Hamilton JB (1939) Significance of sex hormones in tanning of the skin of women. Proc Soc Exp Biol Med 40: 402–503

    Google Scholar 

  • Heimrich SP, Rosenberg L, Kaufman DW, Miller DR, Schottenfeld D, Stolley PD, Shapiro S (1984) Lack of an elevated risk of malignant melanoma in relation to oral contraceptive use. JNCI 72: 617–620

    Google Scholar 

  • Holly EA, Weiss NS, Liff JM (1983) Cutaneous melanoma in relation to exogenous hormones and reproductive factors. JNCI 70: 827–831

    PubMed  CAS  Google Scholar 

  • Holman CDJ, Armstrong BK (1984) Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types. JNCI 73: 75–82

    PubMed  CAS  Google Scholar 

  • Holman CDJ, Armstrong BK, Heenan PJ (1984) Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors. Br J Cancer 50: 673–680

    Article  PubMed  CAS  Google Scholar 

  • Hoover R, Bain C, Cole P, MacMahon B (1978) Oral contraceptive use: association with frequency of hospitalization and chronic disease risk indicators. Am J Public Health 68: 335–341

    Article  PubMed  CAS  Google Scholar 

  • Jadassohn W (1958) Art for art’s sake in medicine. Arch Dermatol 78: 427–437

    Article  CAS  Google Scholar 

  • Kay CR (1981) (letter) Malignant melanoma and oral contraceptives. Br J Cancer 44: 479

    Article  Google Scholar 

  • Ramcharan S, Pellegrin FA, Ray R, Hsu JP (1981) The Walnut Creek contraceptive drug study. A prospective study of the side effects of oral contraceptives, vol III. US Government Printing Office, Washington D.C.

    Google Scholar 

  • Siegel S (1956) Nonparametric statistics. McGraw-Hill, New York, pp 68–75

    Google Scholar 

  • Snell RS, Bischitz PG (1960) The effect of large doses of estrogen and estrogen and progesterone on melanin pigmentation. J Invest Dermatol 35: 73–82

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer-Verlag Berlin · Heidelberg

About this paper

Cite this paper

Holly, E.A. (1986). Cutaneous Melanoma and Oral Contraceptives: A Review of Case-Control and Cohort Studies. In: Gallagher, R.P. (eds) Epidemiology of Malignant Melanoma. Recent Results in Cancer Research, vol 102. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82641-2_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-82641-2_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-82643-6

  • Online ISBN: 978-3-642-82641-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics